Follicle Stimulating Hormone
Sponsors
IBSA Institut Biochimique SA, Medical University of Vienna, Isala, Center for Human Reproduction, Azienda Sanitaria Locale Bari
Conditions
Change in Flow Mediated DilationDiminished Ovarian ReserveDiminished Ovarian Reserve (DOR)Female Infertility Due to Diminished Ovarian ReserveInfertilityMale InfertilityObesityProgesterone Resistance
Early Phase 1
Phase 1
Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF
NCT02179255
Start: 2014-08-01End: 2022-06-30Target: 30Updated: 2020-02-18
Use of Pulsatile Intravenous FSH to Mitigate Reprometabolic Syndrome
RecruitingNCT06414096
Start: 2024-10-01End: 2032-01-01Target: 60Updated: 2026-10-14
Phase 3
Efficacy and Tolerability of Human FSH Versus Recombinant FSH (Follitropin Alpha) in ICSI.
CompletedNCT00335725
Start: 2003-03-31End: 2005-12-31Updated: 2015-03-27
Efficacy of Ovarian Stimulation Based on FSHR Genotype Status
SuspendedNCT00749853
Start: 2015-05-31End: 2015-06-30Target: 165Updated: 2015-05-05